this post was submitted on 21 Dec 2024
42 points (97.7% liked)

Health - Resources and discussion for everything health-related

2398 readers
169 users here now

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you're not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

founded 2 years ago
MODERATORS
 

Summary

The FDA has approved Eli Lilly’s obesity drug Zepbound to treat moderate to severe obstructive sleep apnea (OSA) in people with obesity, marking the first medication for this condition.

Clinical trials showed Zepbound users had 25 fewer breathing interruptions per hour, lost 20% of their body weight, and up to half no longer had OSA symptoms after a year.

This approval is expected to expand insurance coverage, including Medicare, for patients with both obesity and OSA.

It offers an alternative to CPAP devices, the current standard treatment.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here